Premium
Anthralin/dithranol in dermatology
Author(s) -
Sehgal Virendra N.,
Verma Prashant,
Khurana Ananta
Publication year - 2014
Publication title -
international journal of dermatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 93
eISSN - 1365-4632
pISSN - 0011-9059
DOI - 10.1111/j.1365-4632.2012.05611.x
Subject(s) - dithranol , medicine , dermatology , psoriasis , irritation , tea tree oil , drug , pharmacology , immunology , chemistry , chromatography , essential oil
Anthralin (1,8‐dihydroxy‐9anthrone, dithranol) was first synthesized as a derivative of chrysarobin, prepared from the araroba tree in Brazil over a century ago. Drawbacks to the use of anthralin include irritation and discoloration of the skin. This property of the molecule prompted workers to investigate details of its pharmacology, mode of action, and indications. The major point of this article is to highlight and revisit these aspects for pertinent future use. Therefore, it is worthwhile to consider that the drug is relatively innocuous, yet effective, and is devoid of any systemic side effects in contrast to a wide variety of systemic and topical therapies available for psoriasis and other dermatoses.